Answer
Mercaptamine (cysteamine) in Cystadrops reduces corneal cystine crystal accumulation by depleting cystine through conversion to cysteine and cysteine–cysteamine mixed disulfides.
Sources for this answer
- Cystadrops 3.8mg/ml eye dropsRecordati Rare Diseases UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 10Document updated
Sources checked